SH3PXD2A and non-small cell lung carcinoma: This study results revealed that expression of SH3PXD2A-AS1 was upregulated in DDP-resistant NSCLC cell line, whereas recent studies have also shown its upregulation in NSCLC and colorectal cancer [2, 10].